• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of catheter ablation in obese patients: Less complicated than you think.

作者信息

Kowlgi Gurukripa N, Siontis Konstantinos C

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

J Cardiovasc Electrophysiol. 2022 Apr;33(4):664-666. doi: 10.1111/jce.15394. Epub 2022 Feb 9.

DOI:10.1111/jce.15394
PMID:35118744
Abstract
摘要

相似文献

1
Safety of catheter ablation in obese patients: Less complicated than you think.
J Cardiovasc Electrophysiol. 2022 Apr;33(4):664-666. doi: 10.1111/jce.15394. Epub 2022 Feb 9.
2
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.超重和肥胖患者行肺静脉隔离术后心房颤动复发率增加。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14.
3
Comments on impact of obesity on acute complications of catheter ablation for cardiac arrhythmia.肥胖对心律失常导管消融急性并发症影响的述评
J Cardiovasc Electrophysiol. 2022 Jun;33(6):1344. doi: 10.1111/jce.15471. Epub 2022 Apr 5.
4
Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation.肥胖症中的心房颤动：权衡导管消融的证据
Clin Cardiol. 2020 Oct;43(10):1064-1066. doi: 10.1002/clc.23416. Epub 2020 Jun 29.
5
A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation.一项前瞻性研究评估了肥胖和阻塞性睡眠呼吸暂停对心房颤动导管消融术后结局的影响。
J Cardiovasc Electrophysiol. 2010 May;21(5):521-5. doi: 10.1111/j.1540-8167.2009.01653.x. Epub 2009 Nov 17.
6
Catheter ablation for atrial fibrillation in patients with obesity.肥胖患者心房颤动的导管消融治疗
Circulation. 2008 May 20;117(20):2583-90. doi: 10.1161/CIRCULATIONAHA.107.716712. Epub 2008 May 12.
7
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.AF 消融患者的监督减肥试验：SORT-AF 试验结果。
Europace. 2021 Oct 9;23(10):1548-1558. doi: 10.1093/europace/euab122.
8
Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study.随机、对照试验评估接触力感知灌洗导管消融阵发性心房颤动的安全性和有效性：房颤 TactiCath 接触力消融导管研究（TOCCASTAR 研究）结果。
Circulation. 2015 Sep 8;132(10):907-15. doi: 10.1161/CIRCULATIONAHA.114.014092. Epub 2015 Aug 10.
9
Catheter Ablation of Atrial Fibrillation.心房颤动的导管消融术
Heart Fail Clin. 2016 Apr;12(2):223-33. doi: 10.1016/j.hfc.2015.08.018.
10
Extra-pulmonary vein driver mapping and ablation for persistent atrial fibrillation in obese patients.肺静脉外驱动灶标测和消融治疗肥胖患者持续性心房颤动。
Europace. 2021 May 21;23(5):701-709. doi: 10.1093/europace/euaa314.

引用本文的文献

1
Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County.奥尔姆斯特德县非感染性心血管植入式电子设备并发症30年期间的趋势。
Heart Rhythm O2. 2024 Feb 14;5(3):158-167. doi: 10.1016/j.hroo.2024.02.001. eCollection 2024 Mar.